CDC Financial
CDC Financial reported 38 stocks worth $130M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are HCAT (10.8%), INBX (10.2%) and AMPY (7.9%). Compared with Q1 2026, the fund opened new positions in DUOT, AR and NTGR, added to HCAT, INBX and LZ, trimmed IMMR, CENX and THRY and sold out of INTA, UPWK and TECK.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 3 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  HCAT Health Catalyst Inc | $14.1M | 10.8% | 7.1M | +786K (+12%) | 3 of 3 | |
| 2 |  INBX Inhibrx Biosciences Inc | $13.3M | 10.2% | 140K | +16K (+13%) | 3 of 3 | |
| 3 |  AMPY Amplify Energy Corp New | $10.3M | 7.9% | 2.6M | No change | 3 of 3 | |
| 4 |  LZ Legalzoom Com Inc | $9.8M | 7.5% | 1.6M | +1.2M (+308%) | 3 of 3 | |
| 5 |  AESI Atlas Energy Solutions Inc | $9.2M | 7.0% | 553K | +35K (+7%) | 3 of 3 | |
| 6 |  IMMR Immersion Corp | $8.8M | 6.7% | 1.3M | −144K (−10%) | 3 of 3 | |
| 7 |  CENX Century Alum Co | $8.3M | 6.4% | 181K | −65K (−26%) | 3 of 3 | |
| 8 |  VOXR Vox Royalty Corp | $8.3M | 6.4% | 1.8M | +102K (+6%) | 3 of 3 | |
| 9 |  ASTL Algoma Stl Group Inc | $7.1M | 5.4% | 1.7M | +132K (+8%) | 3 of 3 | |
| 10 |  AFCG Advanced Flower Cap Inc | $5.6M | 4.3% | 1.8M | +324K (+22%) | 3 of 3 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
GOHEALTH INC | $1.1M | 753K |
 INTA Intapp Inc | $537K | 21K |
 UPWK Upwork Inc | $515K | 47K |
 TECK Teck Resources Ltd | $184K | 3,550 |
 SNWV Sanuwave Health Inc | $112K | 6,500 |
🔒 Free account: see all 7.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 SPY Spdr S&P 500 ETF TR | Put | $37M | 50K | +34,300 |
 IWM Ishares TR | Put | $27.6M | 92K | +92,000 |
 QQQ Invesco Qqq TR | Put | $23.5M | 32K | +28,400 |
 HUM Humana Inc | Put | $6M | 15K | +15,000 |
INBX Inhibrx Biosciences Inc | Call | $2.8M | 30K | −32,000 |
🔒 Free account: see all 15.
Reported value
last 3 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →CDC Financial 13F FAQ
What does CDC Financial own?
CDC Financial reported 38 stocks worth $130M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are HCAT (10.8%), INBX (10.2%) and AMPY (7.9%). The table above lists every position in the filing (the top 10 without an account).
What did CDC Financial buy and sell in Q2 2026?
Compared with Q1 2026: 7 new positions, 15 added to, 14 trimmed and 7 sold out. New positions include DUOT, AR and NTGR. It sold all of INTA, UPWK and TECK.
When will CDC Financial file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is CDC Financial's portfolio worth?
The Q2 2026 filing reports $130M in US stocks ($239M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.